D1000 Varejo Farma Participacoes (BSP:DMVF3) Research & Development: R$0 Mil (TTM As of Mar. 2026)


BSP:DMVF3 D1000 Varejo Farma Participacoes SA BSP:DMVF3
78 GF Score
Price R$6.82
GF Value R$8.13
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is D1000 Varejo Farma Participacoes Research & Development?

D1000 Varejo Farma Participacoes BSP:DMVF3 -1.16% 78 Research & Development is R$0 Mil as of Mar. 2026. GuruFocus rates BSP:DMVF3 with a GF Score™ of 78/100 and a GF Value™ of R$8.13 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. D1000 Varejo Farma Participacoes's Research & Development for the three months ended in Mar. 2026 was R$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was R$0 Mil.

D1000 Varejo Farma Participacoes  (BSP:DMVF3) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

D1000 Varejo Farma Participacoes Research & Development Related Terms

D1000 Varejo Farma Participacoes Research & Development Historical Data

* Premium members only.

The historical data trend for D1000 Varejo Farma Participacoes's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D1000 Varejo Farma Participacoes Research & Development Chart

D1000 Varejo Farma Participacoes Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

D1000 Varejo Farma Participacoes Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BSP:DMVF3
78GF Score
D1000 Varejo Farma Participacoes SA BSP:DMVF3
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

D1000 Varejo Farma Participacoes Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of R$0 Mil mean?
D1000 Varejo Farma Participacoes (BSP:DMVF3) has a Research & Development of R$0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on D1000 Varejo Farma Participacoes and its competitors.
Is D1000 Varejo Farma Participacoes' Research & Development too high?
D1000 Varejo Farma Participacoes' current Research & Development is R$0 Mil. Overall, D1000 Varejo Farma Participacoes has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does D1000 Varejo Farma Participacoes' Research & Development compare to competitors?
D1000 Varejo Farma Participacoes' Research & Development of R$0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on D1000 Varejo Farma Participacoes and its competitors. D1000 Varejo Farma Participacoes's current Research & Development is R$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D1000 Varejo Farma Participacoes stock overvalued right now?
Based on GuruFocus' analysis, D1000 Varejo Farma Participacoes (BSP:DMVF3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$8.13, compared to a current price of R$6.82 — trading 16.1% below its estimated fair value. The current Research & Development is R$0 Mil. D1000 Varejo Farma Participacoes' overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For D1000 Varejo Farma Participacoes (BSP:DMVF3), the current Research & Development is R$0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D1000 Varejo Farma Participacoes (BSP:DMVF3) Overvalued in 2026?

Based on GuruFocus' analysis, D1000 Varejo Farma Participacoes stock appears to be undervalued. The current stock price of R$6.82 is trading 16.1% below its estimated GF Value™ of R$8.13. GuruFocus considers D1000 Varejo Farma Participacoes to be Modestly Undervalued.

Key valuation signals for BSP:DMVF3:

  • Research & Development: R$0 Mil
  • GF Value™: R$8.13 vs. price of R$6.82 (16.1% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the BSP:DMVF3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

D1000 Varejo Farma Participacoes Business Description

Address Cidade de Deus. Predio Amarelo, 2nd Floor, Osasco, SP, BRA, 6029900
D1000 Varejo Farma Participacoes SA invests in national or foreign pharmaceutical retail companies.
78GF Score

Get the complete analysis for BSP:DMVF3

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$6.82
Price
R$8.13
GF Value